Cargando…

The value of high dose tamoxifen in postmenopausal breast cancer patients progressing on standard doses: a pilot study.

Detalles Bibliográficos
Autor principal:	Watkins, S. M.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1988
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2246518/ https://www.ncbi.nlm.nih.gov/pubmed/3355772

Ejemplares similares

Tamoxifen effects on subjective and psychosexual well-being, in a randomised breast cancer study comparing high-dose and standard-dose chemotherapy
por: Mourits, M J, et al.
Publicado: (2002)

High-dose tamoxifen in high-hormone-receptor-expressing advanced breast cancer patients: a phase II pilot study
por: Su, Yanhong, et al.
Publicado: (2021)

Genotype of metabolic enzymes and the benefit of tamoxifen in postmenopausal breast cancer patients
por: Wegman, Pia, et al.
Publicado: (2005)

AGR2 Predicts Tamoxifen Resistance in Postmenopausal Breast Cancer Patients
por: Hrstka, Roman, et al.
Publicado: (2013)

Effects of tamoxifen and exemestane on cognitive function in postmenopausal patients with breast cancer
por: Lee Meeuw Kjoe, Philippe R, et al.
Publicado: (2023)

Effect of low doses of estradiol and tamoxifen on breast cancer cell karyotypes
por: Rondón-Lagos, Milena, et al.
Publicado: (2016)

High dose ketoconazole: endocrine and therapeutic effects in postmenopausal breast cancer.
por: Harris, A. L., et al.
Publicado: (1988)

A comparison of two doses of tamoxifen (Nolvadex) in postmenopausal women with advanced breast cancer: 10 mg bd versus 20 mg bd.
por: Bratherton, D. G., et al.
Publicado: (1984)

Endocrine and clinical consequences of combination tamoxifen-aminoglutethimide in postmenopausal breast cancer.
por: Dowsett, M., et al.
Publicado: (1984)

Impact of short-term low-dose tamoxifen on molecular breast imaging background parenchymal uptake: a pilot study
por: Hruska, Carrie B., et al.
Publicado: (2019)

Associations between tamoxifen, estrogens, and FSH serum levels during steady state tamoxifen treatment of postmenopausal women with breast cancer
por: Gjerde, Jennifer, et al.
Publicado: (2010)

Therapeutic Drug Monitoring of Endoxifen for Tamoxifen Precision Dosing: Feasible in Patients with Hormone-Sensitive Breast Cancer
por: Braal, C. Louwrens, et al.
Publicado: (2021)

The impact of endoxifen-guided tamoxifen dose reductions on endocrine side-effects in patients with primary breast cancer
por: Buijs, S.M., et al.
Publicado: (2023)

Quality of life in relation to tamoxifen or exemestane treatment in postmenopausal breast cancer patients: a Tamoxifen Exemestane Adjuvant Multinational (TEAM) Trial side study
por: van Nes, J. G. H., et al.
Publicado: (2012)

Effects of low-dose tamoxifen on breast cancer biomarkers Ki-67, estrogen and progesterone receptors
por: de Sousa, Juarez Antônio, et al.
Publicado: (2006)

Oral low dose and topical tamoxifen for breast cancer prevention: modern approaches for an old drug
por: Lazzeroni, Matteo, et al.
Publicado: (2012)

Initiation and tolerance of chemoprevention among women with high-risk breast lesions: the potential of low-dose tamoxifen
por: Bychkovsky, Brittany, et al.
Publicado: (2022)

Phosphorylated p-70S6K predicts tamoxifen resistance in postmenopausal breast cancer patients randomized between adjuvant tamoxifen versus no systemic treatment
por: Beelen, Karin, et al.
Publicado: (2014)

CYP2C19*2 predicts substantial tamoxifen benefit in postmenopausal breast cancer patients randomized between adjuvant tamoxifen and no systemic treatment
por: Beelen, K., et al.
Publicado: (2013)

Effective inhibition by low dose aminoglutethimide of peripheral aromatization in postmenopausal breast cancer patients.
por: Dowsett, M., et al.
Publicado: (1985)

Computational Treatment Simulations to Assess the Need for Personalized Tamoxifen Dosing in Breast Cancer Patients of Different Biogeographical Groups
por: Mueller-Schoell, Anna, et al.
Publicado: (2021)

Tamoxifen use and risk of endometrial cancer in breast cancer patients: A systematic review and dose–response meta‐analysis
por: Ghanavati, Matin, et al.
Publicado: (2023)

Genital tuberculosis in a tamoxifen-treated postmenopausal woman with breast cancer and bloody vaginal discharge
por: Neonakis, Ioannis, et al.
Publicado: (2006)

Tamoxifen in refractory ovarian cancer: the use of a loading dose schedule.
por: Osborne, R. J., et al.
Publicado: (1988)

Endocrine effects of low dose aminoglutethimide alone in advanced postmenopausal breast cancer.
por: Harris, A. L., et al.
Publicado: (1983)

Developmental malformations resulting from high-dose maternal tamoxifen exposure in the mouse
por: Sun, Miranda R., et al.
Publicado: (2021)

Progress in the Understanding of the Mechanism of Tamoxifen Resistance in Breast Cancer
por: Yao, Jingwei, et al.
Publicado: (2020)

Cyclin D1 overexpression is a negative predictive factor for tamoxifen response in postmenopausal breast cancer patients
por: Stendahl, M, et al.
Publicado: (2004)

CYP2D6 genotype affects outcome in postmenopausal breast cancer patients treated with tamoxifen monotherapy
por: Thompson, AM, et al.
Publicado: (2010)

Polypoid endometriosis mimicking invasive cancer in an obese, postmenopausal tamoxifen user
por: Jaegle, William T., et al.
Publicado: (2017)

The value of high adherence to tamoxifen in women with breast cancer: a community-based cohort study
por: McCowan, C, et al.
Publicado: (2013)

Meta-analysis of trials comparing anastrozole and tamoxifen for adjuvant treatment of postmenopausal women with early breast cancer
por: Aydiner, Adnan, et al.
Publicado: (2008)

Oestrogen receptor co-activator AIB1 is a marker of tamoxifen benefit in postmenopausal breast cancer
por: Weiner, M., et al.
Publicado: (2013)

Clinical Trial: CYP2D6 Related Dose Escalation of Tamoxifen in Breast Cancer Patients With Iranian Ethnic Background Resulted in Increased Concentrations of Tamoxifen and Its Metabolites
por: Khalaj, Zahra, et al.
Publicado: (2019)

Tamoxifen-Induced Gastric Injury: Effects of Dose and Method of Administration
por: Keeley, Theresa M., et al.
Publicado: (2019)

Bilateral Macular Hole Related to Tamoxifen Low-Dose Toxicity
por: Torrell Belzach, Nuria, et al.
Publicado: (2020)

Low‐Dose Tamoxifen Induces Significant Bone Formation in Mice
por: Xie, Zhihui, et al.
Publicado: (2021)

Tamoxifen for women at high risk of breast cancer
por: Nazarali, Safia A, et al.
Publicado: (2014)

Mitotic count can predict tamoxifen benefit in postmenopausal breast cancer patients while Ki67 score cannot
por: Beelen, Karin, et al.
Publicado: (2018)

A comparison of the endocrine effects of low dose aminoglutethimide with and without hydrocortisone in postmenopausal breast cancer patients.
por: Dowsett, M., et al.
Publicado: (1985)

Cannot write session to /tmp/vufind_sessions/sess_qic5eir8sbrpcrpla0hr6bvpnd